Industry veteran joins Mundipharma as head of biosimilars

The Mundipharma network of independent associated companies today confirmed the appointment of Philippe Bastide, who joins as head of biosimilars, Mint Commercial.

Mr Bastide, who will report to Chris Surridge, European director of strategy and commercial excellence, brings with him drive and experience gained from over 25 years’ pharma experience. His career includes over five years of biosimilar experience with both Amgen (Nasdaq: AMGN) and Shire (LSE: SHP), in both European and global commercial roles. He started the Amgen European Biosimilars organization then led the overall Shire/Baxalta Biosimilars Unit.

Commenting on his appointment, Mr Bastide said: “Mundipharma has built a reliable and extremely successful biosimilars platform, making them the biosimilars partner of choice in Europe. I believe my global experience, coupled with the commercial skill and collective desire to explore innovative new ways to ensure healthcare systems continue to benefit from biosimilars, will be a winning combination.”